GRMN
40
3
MTB
75
2
HRL
38
3
CVS
41
2
HPE
68
-5
DIS
72
2
DLTR
58
3
NWL
57
3
CRM
59
-11
CNP
55
3
COST
53
5
PLD
33
3
LOW
45
2
PEG
50
4
ES
50
3
MDLZ
28
4
PG
43
2
AAPL
55
2
GWW
65
3
DUK
59
4
GRMN
40
3
MTB
75
2
HRL
38
3
CVS
41
2
HPE
68
-5
DIS
72
2
DLTR
58
3
NWL
57
3
CRM
59
-11
CNP
55
3
COST
53
5
PLD
33
3
LOW
45
2
PEG
50
4
ES
50
3
MDLZ
28
4
PG
43
2
AAPL
55
2
GWW
65
3
DUK
59
4
Financhill
Back

Repligen Corp. 10K Form

Sell
50

RGEN
Repligen Corp.

Last Price:
$165.77
Seasonality Move:
16.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q RGEN/Repligen Corp. Quarterly
2023-10-31 10Q RGEN/Repligen Corp. Quarterly
2023-08-02 10Q RGEN/Repligen Corp. Quarterly
2023-05-02 10Q RGEN/Repligen Corp. Quarterly
2022-11-01 10Q RGEN/Repligen Corp. Quarterly
2022-08-02 10Q RGEN/Repligen Corp. Quarterly

Receive RGEN News And Ratings

See the #1 stock for the next 7 days that we like better than RGEN

RGEN Financial Statistics

Sales & Book Value

Annual Sales: $634.4M
Cash Flow: $42.7M
Price / Cash Flow: 90.32
Annual Sales: $37.01
Price / Book: 4.48

Profitability

EPS (TTM): 0.02580
Net Income (TTM): $1.7M
Gross Margin: $284M
Return on Equity: 0.09%
Return on Assets: 0.06%

Repligen Corp. Earnings Forecast

Key Repligen Corp. Financial Ratios

  • The Gross Profit Margin over the past 40 years for RGEN is 44.76%.
  • The Selling, General & Administrative Expenses for RGEN have been equal to 41.51% of Gross Profit Margin.
  • The Research & Development expenses have been 6.74% of Revenue.
  • The Net Earning history of RGEN is -4.02% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 18 years.

Repligen Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: RGEN
CUSIP: 759916
Website: repligen.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 8.36
Quick Ratio: 6.86

Price-to-Earnings

Trailing P/E Ratio: 258.21
Forward P/E Ratio: 79.59

RGEN Technical Analysis vs Fundamental Analysis

Sell
50
Repligen Corp. (RGEN) is a Sell

Is Repligen Corp. a Buy or a Sell?

  • Repligen Corp. stock is rated a Sell
    The current Repligen Corp. [RGEN] share price is $165.66. The Score for RGEN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.